Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.7.0.1
Summary of Significant Accounting Policies (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 01, 2016
Dec. 31, 2015
Mar. 31, 2017
USD ($)
Segment
Mar. 31, 2016
USD ($)
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Summary of Significant Accounting Policies [Line Items]            
Provision for inventory obsolescence     $ 4,600 $ 0    
Goodwill, in-process research and development and other intangible assets acquired     2,100,000     $ 2,100,000
Amortization expense     17,929 13,443    
In-process research and development     645,058     644,713
Intangible assets, net     746,654     763,976
Depreciation expense     7,800 8,700    
Deferred revenue     145,100     162,400
Revenue from transfer of intellectual property and other     18,579 18,616    
Accounts receivable, gross     283,780     256,552
Allowance for doubtful accounts receivable     44,887     36,268
Provision for bad debts     27,000 19,600    
Equity-based compensation expense     $ 9,693 17,307    
Number of reportable segments | Segment     2      
Minimum            
Summary of Significant Accounting Policies [Line Items]            
Intangible assets, estimated useful lives     3 years      
Maximum            
Summary of Significant Accounting Policies [Line Items]            
Intangible assets, estimated useful lives     20 years      
Government Contracts Concentration Risk            
Summary of Significant Accounting Policies [Line Items]            
Accounts receivable, gross     $ 43,500     $ 50,500
Government Contracts Concentration Risk | Sales Revenue, Net            
Summary of Significant Accounting Policies [Line Items]            
Concentration percentage     21.00%      
Software            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     3 years      
Machinery, Medical and Other Equipment | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     5 years      
Machinery, Medical and Other Equipment | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     8 years      
Furniture and Fixtures | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     5 years      
Furniture and Fixtures | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     10 years      
Buildings and Improvements | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     10 years      
Buildings and Improvements | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     40 years      
Automobiles and Aircraft | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     3 years      
Automobiles and Aircraft | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives     15 years      
Collaborative Arrangement, Product | Pfizer            
Summary of Significant Accounting Policies [Line Items]            
Deferred revenue     $ 141,200      
Revenue from transfer of intellectual property and other     $ 17,700 17,700    
Self-Pay | Accounts Receivable            
Summary of Significant Accounting Policies [Line Items]            
Concentration percentage     3.40%     4.10%
Internal Revenue Service (IRS)            
Summary of Significant Accounting Policies [Line Items]            
Corporate income tax rate     35.00%      
Israel Tax Authority            
Summary of Significant Accounting Policies [Line Items]            
Corporate income tax rate 24.00% 25.00% 23.00%      
Scenario, Adjustment            
Summary of Significant Accounting Policies [Line Items]            
In-process research and development         $ (187,600)  
Intangible assets, net         $ 187,600  
In-process Research and Development            
Summary of Significant Accounting Policies [Line Items]            
Intangible assets, estimated useful lives         12 years  
Rayaldee [Member]            
Summary of Significant Accounting Policies [Line Items]            
Deferred revenue     $ 2,100      
Accounting Standards Update 2016-09            
Summary of Significant Accounting Policies [Line Items]            
Deferred tax asset       32,500    
Accumulated Deficit | Accounting Standards Update 2016-09            
Summary of Significant Accounting Policies [Line Items]            
Cumulative effect of new accounting update       $ (33,700)